Chrysalis Day Program Body Mass Index Study - Full Text View

Sponsored by:	Queen's University
Information provided by:	Queen's University
ClinicalTrials.gov Identifier:	NCT00202215

Purpose

This is a study to determine if the approach taken to treat patients in the Chrysalis Day Hospital Program will favourably effect their health status as assessed by Body Mass Index (BMI)

Condition	Intervention
Borderline Personality Disorder Eating Disorders	Behavioral: Chrysalis Day Program

MedlinePlus related topics: Eating Disorders Personality Disorders

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:	A Study on the Effects of a Personality Disorder Day Hospital Program on Clients Body Mass Index

Further study details as provided by Queen's University:

Primary Outcome Measures:

Body Mass Index at time of enrolling in programme and at leaving [ Time Frame: at entry and upon leaving the program ]

Secondary Outcome Measures:

patient demographics relationship to outcome [ Time Frame: upon entry and exit from the program ]
programme changes and relation to outcome [ Time Frame: from start to the end of the study ]

Enrollment:	106
Study Start Date:	October 2001
Study Completion Date:	June 2007

Detailed Description:

As part of the Providence Continuing Care Center's continuing quality improvement initiatives this study is to more systematically evaluate the success of the Chrysalis Day Hospital Program in dealing with some features of eating disorders commonly experienced by its patients.

At intake all clients will be approached to give informed consent to participate. If they do consent they will have their height and weight recorded( if they request they will not be told their weight)as part of the usual intake process conducted by a dietician.

When clients exit the program they again will be approached to be weighed. The body mass index will be calculated and compared to admission values.

The Chrysalis Program is a unique day hospital approach to treating individuals with severe personality disorders (primarily Borderline)that views the eating disordered behaviour common to these clients as a symptom of many and by addressing core issues of affect dysregulation as well as psychoeducation about eating the eating problems will improve .

Eligibility

Ages Eligible for Study:	16 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

clients of the Chrysalis Program

Exclusion Criteria:

clients of the Chrysalis Program who do not consent to the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00202215

Locations

Canada, Ontario
Providence Care Centre Mental Health Services
Kingston, Ontario, Canada, K7L 4X3

Sponsors and Collaborators

Queen's University

Investigators

Principal Investigator:

Stephen H McNevin, MD

Queens University

More Information

describes the chrysalis program This link exits the ClinicalTrials.gov site

Study ID Numbers:	PDS002
Study First Received:	September 9, 2005
Last Updated:	October 15, 2007
ClinicalTrials.gov Identifier:	NCT00202215
Health Authority:	Canada: Health Canada

Keywords provided by Queen's University:

Day hospital treatment

Study placed in the following topic categories:

Mental Disorders
Borderline Personality Disorder
Eating Disorders
Personality Disorders

Additional relevant MeSH terms:

Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 15, 2009